Our Mission at GNT Animal Health
We aim to provide products that go beyond merely treating and controlling animal diseases.
GNT Animal Health
Introduction
INTRODUCTION
GNT Pharma is dedicated to discovering and developing innovative drugs for patients with neurological
disorders and supporting their families in the absence of effective treatments. In 2018, we established
GNT Animal Health (GAH) to leverage over 20 years of R&D expertise in creating treatments that enhance
companion animal health and improve owners' quality of life. GAH successfully adapted our Alzheimer’s Disease treatment
for Canine Cognitive Dysfunction Syndrome (CCDS), achieved approval as a new veterinary medicine.
Looking ahead, GAH will continue developing competitive products for global markets, guided by top experts in the field.
disorders and supporting their families in the absence of effective treatments. In 2018, we established
GNT Animal Health (GAH) to leverage over 20 years of R&D expertise in creating treatments that enhance
companion animal health and improve owners' quality of life. GAH successfully adapted our Alzheimer’s Disease treatment
for Canine Cognitive Dysfunction Syndrome (CCDS), achieved approval as a new veterinary medicine.
Looking ahead, GAH will continue developing competitive products for global markets, guided by top experts in the field.
Advancements in veterinary medicine and increased dog life expectancy
have led to a rise in neurodegenerative diseases.
have led to a rise in neurodegenerative diseases.
In 2018, GNT Pharma launched GNT Animal Health to alleviate the suffering of dogs and their families.
GedaCure®, the world’s first treatment for Canine Cognitive Dysfunction Syndrome (CCDS), is aimed at improving the lives of dogs and their owners.
As we venture into uncharted territory, we are committed to taking bold steps with a strong sense of responsibility. Our dedication to research and development will continue, with a focus on bringing greater happiness to dogs and their families. Ultimately, we aim to reach global markets and help dogs suffering from CCDS worldwide.
Jinhwan Lee, GNT Animal Health COO
MISSION
INNOVATION
Innovative research to promote
the welfare of both companion
animals and family caregivers
the welfare of both companion
animals and family caregivers
TRUST
Development of reliable products by
pursuing safety and professionality
pursuing safety and professionality
EXCELLENCE
Advanced technology recognized
in the global market
in the global market